- Home
- WETH vs IMNN Comparison
WETH vs IMNN Comparison
Compare WETH & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WETH
- IMNN
- Stock Information
- Founded
- WETH 1992
- IMNN 1982
- Country
- WETH China
- IMNN United States
- Employees
- WETH N/A
- IMNN N/A
- Industry
- WETH
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- WETH
- IMNN Health Care
- Exchange
- WETH Nasdaq
- IMNN Nasdaq
- Market Cap
- WETH 10.9M
- IMNN 12.1M
- IPO Year
- WETH N/A
- IMNN 1985
- Fundamental
- Price
- WETH $0.90
- IMNN $1.02
- Analyst Decision
- WETH
- IMNN Buy
- Analyst Count
- WETH 0
- IMNN 2
- Target Price
- WETH N/A
- IMNN $14.00
- AVG Volume (30 Days)
- WETH 40.4K
- IMNN 32.7M
- Earning Date
- WETH 08-18-2025
- IMNN 08-13-2025
- Dividend Yield
- WETH N/A
- IMNN N/A
- EPS Growth
- WETH N/A
- IMNN N/A
- EPS
- WETH 0.34
- IMNN N/A
- Revenue
- WETH $41,024,264.00
- IMNN N/A
- Revenue This Year
- WETH N/A
- IMNN N/A
- Revenue Next Year
- WETH N/A
- IMNN N/A
- P/E Ratio
- WETH $2.62
- IMNN N/A
- Revenue Growth
- WETH 2.86
- IMNN N/A
- 52 Week Low
- WETH $0.76
- IMNN $0.37
- 52 Week High
- WETH $3.62
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- WETH 38.18
- IMNN 44.27
- Support Level
- WETH $0.86
- IMNN $0.93
- Resistance Level
- WETH $0.98
- IMNN $2.12
- Average True Range (ATR)
- WETH 0.06
- IMNN 0.33
- MACD
- WETH -0.00
- IMNN -0.10
- Stochastic Oscillator
- WETH 53.29
- IMNN 4.04
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).